The Efficacy and Safety of Apatinib in Advanced Synovial Sarcoma: A Case Series of Twenty-One Patients in One Single Institution

BACKGROUND: Synovial sarcoma (SS) is a highly aggressive soft-tissue sarcoma (STS) with poor prognosis. Tyrosine kinase inhibitor (TKI) has shown a promising impact on advanced STS patients. This study aimed to evaluate the efficacy and safety of apatinib, an oral multi-TKI, which especially inhibit...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Manag Res
Huvudupphovsmän: Wang, Yitian, Lu, Minxun, Zhou, Yong, Zhou, Sisi, Yu, Xinzhu, Tang, Fan, Luo, Yi, Zhang, Wenli, Duan, Hong, Min, Li, Tu, Chongqi
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove 2020
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7335867/
https://ncbi.nlm.nih.gov/pubmed/32669874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S254296
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk